GlassScriptPhysician profile
Silas Klaver
NPI 1093194425
$5,057.10
in general payments reported to CMS, 2019-2025
7 companies · $739 in 2025
The $739 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $1,476 · 2023: $347 · 2024: $2,307 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,703 · Travel and Lodging: $1,690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,703.11 |
| Travel and Lodging | $1,689.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,396.93 | 2021-2025 | Inbone, Prophecy, Prostep |
| Paragon 28, INC. | $1,335.02 | 2022-2025 | Apex 3d, Additive Orthopedics |
| Gemini Mountain Medical, LLC | $1,200.00 | 2022 | |
| Avanos Medical | $51.28 | 2023-2025 | On-Q Pump and Accessories, On-Q* Pump and Accessories |
| Smith+Nephew, INC. | $45.75 | 2022-2025 | Grafix Pl |
| Baxter Healthcare | $14.25 | 2025 | Perclot |
| Bioventus LLC | $13.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silas Klaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.